Ahsan T, Lottman L M, Harwood F, Amiel D, Sah R L
Department of Bioengineering, Institute for Biomedical Engineering, University of California-San Diego, La Jolla 92093-0412, USA.
J Orthop Res. 1999 Nov;17(6):850-7. doi: 10.1002/jor.1100170610.
The effects of beta-aminopropionitrile, a known inhibitor of lysyl oxidase, on the extractability of newly synthesized collagen and integrative cartilage repair were determined in explant cultures of adult bovine articular cartilage. Dose-escalation studies indicated that treatment of cartilage explants for 6 days with beta-aminopropionitrile caused a dose-dependent inhibition of proteoglycan synthesis ([35S]sulfate incorporation) with a 50% inhibition at 2.2 mM. However, 0.25 mM beta-aminopropionitrile had no detectable effect on proteoglycan synthesis and was thus used for subsequent experiments. Treatment of cartilage with beta-aminopropionitrile for 14 days increased the extractability of newly synthesized collagen with 4 M guanidine-HCl while having little effect on proteoglycan synthesis, proteoglycan deposition, collagen synthesis (formation of [3H]hydroxyproline after labeling with [3H]proline), collagen deposition, or cartilage cellularity (DNA content). In untreated cultures, the percentage of radiolabeled collagen ([3H]hydroxyproline) that was extractable after 1 day of radiolabeling, 6 days of radiolabeling, or 6 days of label and 6 days of chase decreased from 81 to 25 and 9%, respectively. In beta-aminopropionitrile-treated cultures, the extractability was relatively higher (96, 62, and 47%, respectively). Treatment with beta-aminopropionitrile after radiolabeling with [14C]lysine also significantly inhibited the formation of the reducible crosslink [14C]dihydroxylysinonorleucine without affecting the overall deposition in cartilage of [14C]lysine and [14C]hydroxylysine. In functional repair studies, treatment with beta-aminopropionitrile caused an almost complete inhibition of integration between pairs of cartilage explants maintained in apposition for 2 weeks. These results indicate that beta-aminopropionitrile blocks the formation of collagen crosslinks in cartilage explants and suggest that such crosslinks are critical to integrative cartilage repair.
在成年牛关节软骨外植体培养中,测定了已知的赖氨酰氧化酶抑制剂β-氨基丙腈对新合成胶原蛋白的可提取性和软骨整合修复的影响。剂量递增研究表明,用β-氨基丙腈处理软骨外植体6天会导致蛋白聚糖合成([35S]硫酸盐掺入)呈剂量依赖性抑制,在2.2 mM时抑制率为50%。然而,0.25 mM的β-氨基丙腈对蛋白聚糖合成没有可检测到的影响,因此用于后续实验。用β-氨基丙腈处理软骨14天可增加新合成胶原蛋白在4 M盐酸胍中的可提取性,而对蛋白聚糖合成、蛋白聚糖沉积、胶原蛋白合成(用[3H]脯氨酸标记后[3H]羟脯氨酸的形成)、胶原蛋白沉积或软骨细胞数量(DNA含量)影响很小。在未处理的培养物中,放射性标记1天、6天或6天标记加6天追踪后可提取的放射性标记胶原蛋白([3H]羟脯氨酸)百分比分别从81%降至25%和9%。在β-氨基丙腈处理的培养物中,可提取性相对较高(分别为96%、62%和47%)。用[14C]赖氨酸进行放射性标记后用β-氨基丙腈处理也显著抑制了可还原交联物[14C]二羟基赖氨酸正亮氨酸的形成,而不影响[14C]赖氨酸和[14C]羟赖氨酸在软骨中的总体沉积。在功能修复研究中,用β-氨基丙腈处理几乎完全抑制了并置2周的软骨外植体对之间的整合。这些结果表明,β-氨基丙腈可阻断软骨外植体中胶原蛋白交联的形成,并表明这种交联对软骨整合修复至关重要。